GLP-1 Medications: The Hidden Risk of Muscle Loss Without Exercise

Without exercise, much of the weight lost on GLP-1 medications can come from muscle rather than fat. Learn how exercise protects strength, muscle and long-term health.

GLP-1 Medications: The Hidden Risk of Muscle Loss Without Exercise
GLP-1 receptor agonists are a class of medications prescribed for the management of obesity and Type 2 diabetes. Medications such as Ozempic, Wegovy and Mounjaro have become increasingly popular due to their ability to support significant weight loss while improving glycaemic control as part of a comprehensive weight management plan.

While GLP-1 medications can produce impressive weight loss results, the weight lost is not always exclusively body fat. Research suggests that a substantial proportion of weight lost during GLP-1 treatment may come from lean muscle mass, with some studies reporting that between 40% and 60% of total weight loss may be attributed to muscle rather than fat.

This is an important consideration because lean muscle mass plays a critical role in overall health. Significant muscle loss can negatively impact physical function, metabolic health, and long-term wellbeing, while potentially increasing the risk of chronic health conditions later in life.

Why Preserving Muscle Mass Matters

Lean muscle mass is essential for both physiological function and everyday activities. At a cellular level, muscle plays a key role in blood glucose regulation and metabolism.

From a practical perspective, muscle strength and quality influence your ability to perform daily tasks safely and independently. When muscle mass declines, individuals may experience reduced strength, impaired physical function, and decreases in metabolic efficiency.

For people undergoing medical weight loss, preserving muscle should be a priority alongside reducing body fat.

Resistance Training and GLP-1 Treatment

Resistance exercise is one of the most effective strategies for maintaining muscle mass during GLP-1 treatment. Research has shown that combining exercise with GLP-1 therapy produces superior outcomes compared to medication alone.

In addition to helping preserve lean muscle mass, exercise may provide benefits such as reduced systemic inflammation and improved weight maintenance following the completion of drug therapy.

By incorporating resistance training into a medical weight loss plan, individuals can help ensure that more of their weight loss comes from fat tissue while maintaining strength, function, and overall health.

The Importance of Bone Health During Rapid Weight Loss

Resistance training offers benefits beyond muscle preservation. It also helps maintain and improve bone mineral density, reducing the risk of fractures and injury later in life. Rapid weight loss can lead to significant changes in bone structure and integrity.

While research examining GLP-1 medications and bone health remains limited, long-term studies of patients who have experienced significant weight loss following bariatric surgery have found an increased risk of fracture. This appears to be related to both reductions in bone mass and structural changes within the bone itself. Resistance training and weight-bearing exercise can help offset these changes, supporting bone strength and reducing the risk of future disability associated with fractures.

Impact Exercise for Bone Strength

Impact-based exercise is another important tool for maintaining bone health during medical weight loss. Activities such as jumping, landing drills, skipping and stomping exercises place beneficial forces through the skeleton, stimulating the maintenance and development of healthy bone tissue. Research suggests these exercises need to be performed consistently for at least 6 to 12 months to produce meaningful improvements in bone health.

For individuals undergoing medical weight loss, these exercises can be a valuable long-term investment in future mobility and independence.

Don’t Forget Cardiovascular Exercise

Cardiovascular exercise should also form part of a comprehensive medical weight loss program. Aerobic exercise creates positive adaptations within the heart, lungs and vascular system, helping reduce the risk of conditions such as high blood pressure, stroke and heart disease.

Although weight loss itself is beneficial, it does not necessarily address all of the factors that contribute to long-term health risks. Cardiovascular training helps improve overall fitness and supports better health outcomes beyond changes seen on the scale.

Why Work With an Exercise Physiologist?

Medical weight loss using GLP-1 medications can result in significant physical changes over a relatively short period of time. As body composition changes, so too can movement patterns, exercise tolerance and physical function.

Working with an Exercise Physiologist ensures that your exercise program is tailored to your individual needs, goals and response to treatment. Exercise Physiologists have an in-depth understanding of the body’s physiological systems and can apply the latest evidence to develop safe and effective exercise plans.

No two individuals will respond to GLP-1 medications in exactly the same way. An Exercise Physiologist can adapt your program as your body changes, helping you maximise results while minimising potential risks.

As research into GLP-1 medications continues to evolve, Exercise Physiologists are uniquely positioned to translate emerging evidence into practical recommendations that can be applied to each individual.

The Bottom Line

GLP-1 medications are powerful tools for weight management and improving metabolic health, but they are only one part of the picture. Without exercise, a significant proportion of weight loss may come from muscle rather than fat.

Combining GLP-1 treatment with resistance training, impact exercise and cardiovascular exercise can help preserve muscle mass, maintain bone health, improve physical function and support long-term success.

When guided by an Exercise Physiologist, exercise becomes more than an adjunct to treatment. It becomes a critical component of achieving healthier, stronger and more sustainable outcomes.

References

  • Codella R, Senesi P, Luzi L. GLP-1 agonists and exercise: the future of lifestyle prioritization. Front Clin Diabetes Healthc. 2025 Nov 24;6:1720794. doi: 10.3389/fcdhc.2025.1720794. PMID: 41367404; PMCID: PMC12683586.
  • Mollero ELM, Dozzani I, Biamonte E, Bendotti G, Marzullo P, Aimaretti G, Gallo M. Beyond Weight Loss: Skeletal Muscle Health During Incretin-Based Therapy in Patients with Diabesity. Nutrients. 2026 Aug 14;18(16):2654. doi: 10.3390/nu18162654. PMID: 42654234.
  • Moscucci F, Baratta F, Pastori D, Menichelli D, Mattioli AV, Gallina S, Lospinuso I, Sciomer S, Piccirillo G, Desideri G. A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass. Nutrients. 2026 Feb 14;18(4):632. doi: 10.3390/nu18040632. PMID: 41754149; PMCID: PMC12943638.